In glutamine-addicted squamous cell carcinoma (SCC) cancer cells, V-9302 treatment inhibits the YAP1/TEAD signaling pathway to weaken the SCC cancer phenotype (Mickle, 2022)
Off-Label Dosing Protocols Used in Clinical Practice Because no clinical trials have established human dosing, all dosing information below reflects empirical protocols used by peptide-prescribing clinicians
FDA-approved medications like Zepbound, Oral Wegovy, and Foundayo are generally supported by insurance, and Klinic provides assistance with prior authorization for tirzepatide in Hawley, Pennsylvania
Scientists identified two main hormones responsible: Glucose-dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide (GLP-1)
FDA Archives
Actionable Insights: The foundational biomarkersincluding HbA1c, metabolic panels, and kidney function markersmove the needle on long-term healthspan